CHRISTY WILSON: Open Payments
NPI 1518980762 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,268 in 114 payments from 18 companies in 2025. Trend: 2023 $473 · 2024 $902 · 2025 $2,268
Food & beverage: $2,268
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $409 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $359 |
| Otsuka America Pharmaceutical, Inc. | 13 | $292 |
| Supernus Pharmaceuticals, Inc. | 10 | $238 |
| Alkermes, Inc. | 10 | $186 |
| ABBVIE INC. | 14 | $155 |
| Corium, LLC | 7 | $120 |
| Janssen Pharmaceuticals, Inc | 5 | $83 |
| Lundbeck LLC | 4 | $75 |
| Braeburn Inc. | 4 | $68 |
Products named: CAPLYTA, AUSTEDO XR, Qelbree, REXULTI, VRAYLAR, UZEDY, ARISTADA, Azstarys.
Industry payments across KY — which companies pay providers there.
